Physician

Michael Donald Radosevich, M.D., P.H.D.

According to 2025 Medicare claims, Michael Radosevich, M.D., P.H.D. (NPI: 1932136827) practices ophthalmology in the Albany-Schenectady-Troy, NY market, with the plurality of this provider's patient population coming from Saratoga, NY. This provider's primary affiliated billing organization is CAPITAL REGION RETINA, PLLC (NPI: 1982888988; TIN: 261078622) and primary practice location at 12206-1099.

Radosevich's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 636 traditional Medicare patients, billed 6,103 HCPCS/CPT codes, and received $771,658 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 260 prescription claims across 70 beneficiaries totaling $7,433 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 22 records totaling $598. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have fallen sharply in recent years, from $44,485 to $7,433. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	570	7,721	$1,089,198
2016	641	7,488	$1,022,129
2017	632	6,519	$877,407
2018	643	6,135	$874,236
2019	661	5,954	$843,065
2020	628	5,465	$818,470
2021	623	5,385	$876,922
2022	626	4,814	$693,177
2023	632	5,120	$656,584
2024	636	6,103	$771,658

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	124	558	$44,485
2016	85	433	$32,232
2017	92	375	$27,913
2018	100	486	$26,789
2019	101	436	$24,825
2020	86	352	$22,687
2021	81	308	$14,320
2022	81	343	$13,227
2023	85	308	$11,189
2024	70	260	$7,433

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
J0178	Injection, aflibercept, 1 mg	68	672	$649
67028	Injection of drug into eye	105	523	$90
92014	Established patient complete exam of visual system	608	1,459	$90
76512	2d ultrasound scan of eye tissue and structures	82	122	$35
92134	Imaging of retina	496	1,668	$30

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Prednisolone Acetate	Prednisolone Acetate	69	3,231	$3,163
Dorzolamide Hcl	Dorzolamide Hcl	47	2,574	$858
Brimonidine Tartrate	Brimonidine Tartrate	43	1,187	$623
Ofloxacin	Ofloxacin	41	1,119	$608
Ketorolac Tromethamine	Ketorolac Tromethamine	23	790	$439

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	22	$598	Astellas Pharma US Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Michael Donald Radosevich, M.D., P.H.D.?

Tedicare shows public-source Medicare data for Michael Donald Radosevich, M.D., P.H.D. (NPI 1932136827), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Michael Donald Radosevich, M.D., P.H.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Michael Donald Radosevich, M.D., P.H.D.?

Michael Donald Radosevich, M.D., P.H.D. is linked to CAPITAL REGION RETINA, PLLC (billing NPI 1982888988) in the available physician profile data.

Does Michael Donald Radosevich, M.D., P.H.D. have Open Payments data?

Michael Donald Radosevich, M.D., P.H.D. has 22 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.